Braveheart Bio is targeting a $300 million IPO to advance BHB-1893, a promising HCM treatment. BRVE’s candidate showed an 86% complete response rate in Phase 2 Chinese ...

WSW, NY, July 30th, 2026, FinanceWireOn July 27, 2026, Entera Bio (NASDAQ: ENTX) shocked the market when it announced an ...

Rugonersen, a potentially best-in-class antisense oligonucleotide (ASO) therapy in development for Angelman syndrome, advanced into the pivotal ...

Lantern Pharma Inc. (NASDAQ: LTRN), a clinical-stage, AI-native biopharma company using its proprietary RADR® artificial intelligence and machine-learning platform to develop precision oncology ...

As a biology undergraduate at the University of Notre Dame in Indiana, Jim Elser was looking for direction when he joined a ...

Researchers found that semaglutide, the active ingredient in Ozempic and Wegovy, slowed biological aging markers in adults with HIV, marking the first clinical evidence that the drug may influence ...

After Ranchi’s Avni Kejriwal secured a perfect 500 out of 500 following re-evaluation, another CBSE Class 12 student, Aditya Mishra, has emerged as a joint national topper in the Science stream after ...

Anthropic Tuesday publicly released Claude Fable 5, its first “Mythos-class” model that it says surpasses its previous frontier Opus models in overall capabilities. But the model’s launch today comes ...

CBSE Re-evaluation 2026: The family had urged CBSE to ensure that all answer sheets are made available. CBSE Class 12 Re-evaluation 2026: A Class 12 student in Delhi, who had alleged discrepancies in ...

Clinical update anticipated in mid-2026 for Phase 1 autoimmune program evaluating prulacabtagene leucel (prula-cel, formerly ADI-001) with at least 20 lupus nephritis (LN) and systemic lupus ...

Editor’s Note: All biographies and lists for top 10 students are provided by the school. FAIRHAVEN — The following students are graduating from Fairhaven High School at the top of the 2026 senior ...

Shortly after locking down its $4.8 billion deal for rare disease compatriot Amicus Therapeutics, BioMarin Pharmaceutical is consolidating the workforce tied to the acquired company’s headquarters in ...